Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $183,512 - $271,857
-899 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $8,198 - $10,082
-22 Reduced 2.39%
899 $371,000
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $6,471 - $8,176
22 Added 2.45%
921 $341,000
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $199,578 - $227,105
899 New
899 $225,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.